Market Research Logo

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2018 provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Positron Emission Tomography (PET) Systems Overview
3 Products under Development
3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies
4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
5 Positron Emission Tomography (PET) Systems Companies and Product Overview
5.1 Brain Biosciences Inc Company Overview
5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 GE Healthcare LLC Company Overview
5.2.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 General De Equipment for Medical Imaging SA Company Overview
5.3.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Jagiellonian University Company Overview
5.4.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
5.5 Lightpoint Medical Ltd Company Overview
5.5.1 Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Philips Healthcare Company Overview
5.6.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
5.7 Ray Vision Intl Corp. Company Overview
5.7.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Stanford University Company Overview
5.8.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.9 SynchroPET Company Overview
5.9.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
5.10 University of British Columbia Company Overview
5.10.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
5.11 University of California Davis Company Overview
5.11.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
5.12 University of Washington Company Overview
5.12.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview
5.13 West Virginia University Company Overview
5.13.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
6 Positron Emission Tomography (PET) Systems- Recent Developments
6.1 Mar 12, 2018: Zecotek Introduces Innovative Wireless ASIC Microchip For Positron Emission Tomography Medical Imaging
6.2 Mar 06, 2018: Agfa HealthCare and Hitachi Healthcare Americas Will Cover Full Imaging Portfolio at AAOS 2018 Booth
6.3 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
6.4 Feb 13, 2018: SNMMI and ASNC Issue Joint Guidelines for Quantification of Myocardial Blood Flow Using PET
6.5 Feb 06, 2018: AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference
6.6 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics
6.7 Jan 16, 2018: Oncovision, Enhancing Precision Medicine at RSNA’17
6.8 Jan 16, 2018: Siemens Healthineers lays out strategy to bolster market leadership beyond 2025
6.9 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move
6.10 Jan 03, 2018: Total-Body PET: Maximizing Sensitivity for Clinical Research and Patient Care
6.11 Dec 11, 2017: Presurgical imaging may predict whether epilepsy surgery will work
6.12 Dec 08, 2017: Molecular beacon signals low oxygen with ultrasound
6.13 Dec 06, 2017: PET Tracer Gauges Effectiveness of Promising Alzheimer’s Treatment
6.14 Nov 30, 2017: In the Samara Region, the First Regional Nuclear Medical Center Has Opened
6.15 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange
6.16 Nov 17, 2017: Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017
6.17 Nov 07, 2017: Diagnosing Alzheimer's With Diamonds and PET Scans
6.18 Oct 30, 2017: European OEM Adopts Zecotek’s LFS Scintillation Crystal for Line of Positron Emission Tomography Medical Scanning Devices
6.19 Oct 24, 2017: Michael J. Fox Foundation and Tau Consortium Announce Partnership to Develop New Imaging Tools for Devastating Neurodegenerative Diseases
6.20 Sep 25, 2017: IXICO to provide specialist MR and PET imaging services in Phase II Huntington's disease clinical trial
6.21 Sep 19, 2017: PET imaging tracks Zika virus infection, disease progression in mouse model
6.22 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth
6.23 Aug 22, 2017: Clinical Study Shows that Retinal Imaging may Detect Signs of Alzheimer’s Disease
6.24 Aug 16, 2017: LFS Scintillation Crystals for Neuropet Brain Scanning Device
6.25 Aug 10, 2017: New measure of insulin-making cells could gauge diabetes progression, treatment
6.26 Aug 10, 2017: Dynasil's RMD Subsidiary Awarded $2.1 Million in Technology Development Grants by the National Institute of Health and NASA
6.27 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe
6.28 Jul 24, 2017: USF Health Byrd Alzheimer’s Institute finds amyloid PET scan leading to better Alzheimer’s disease management
6.29 Jul 17, 2017: Zecotek China Appoints Business Development Director
6.30 Jul 06, 2017: Novel PET Tracer Detects Small Blood Clots
6.31 Jul 04, 2017: Zecotek Receives $1.2 Million purchase orders for Patented LFS Scintillation Crystals
6.32 Jun 30, 2017: Zecotek China Working with PET OEMs and Gaining Access to Industries Beyond Medical Scanning
6.33 Jun 24, 2017: European Hematology Association: Early Metabolic Response Determination by FDG-PET Allows Substantial Reduction of Chemotherapy and its Toxicity in Patients with Advanced Stage Hodgkin Lymphoma
6.34 Jun 14, 2017: PET imaging to predict tumor response
6.35 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery
6.36 May 31, 2017: Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017
6.37 May 30, 2017: Zecotek Receives $100,000 Order for Patented LFS Scintillation Crystals from Major Chinese OEM
6.38 May 25, 2017: Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
6.39 May 24, 2017: Zecotek Delivers Patented LFS Scintillation Crystals to Multiple High Tech Institutions
6.40 May 16, 2017: Zecotek Provides Update to Exclusive Distribution Agreement With EBO Optoelectronics and Establishes Subsidiary in China
6.41 May 15, 2017: Threshold Pharmaceuticals Reports First Quarter Financial Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: CerePET - Product Status
Table 9: CerePET - Product Description
Table 10: FREEMotion - Product Status
Table 11: FREEMotion - Product Description
Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Q.Clear - Product Status
Table 14: Q.Clear - Product Description
Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
Table 16: CareMiBrain - Product Status
Table 17: CareMiBrain - Product Description
Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Positron Emission Tomography System - Product Status
Table 20: Positron Emission Tomography System - Product Description
Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: HARLI - Product Status
Table 23: HARLI - Product Description
Table 24: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Additional PET Scan - Product Status
Table 26: Additional PET Scan - Product Description
Table 27: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Helmet - PET System - Product Status
Table 29: Helmet - PET System - Product Description
Table 30: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Breast-Dedicated PET System - Product Status
Table 32: Breast-Dedicated PET System - Product Description
Table 33: Dual Panel PET Scanner - Product Status
Table 34: Dual Panel PET Scanner - Product Description
Table 35: Dual-isotope Positron Emitting Tomography System - Product Status
Table 36: Dual-isotope Positron Emitting Tomography System - Product Description
Table 37: MR Compatible PET System - Product Status
Table 38: MR Compatible PET System - Product Description
Table 39: Next Generation TOF-PET System - Product Status
Table 40: Next Generation TOF-PET System - Product Description
Table 41: PET Sensitivity Enhancing Device - Product Status
Table 42: PET Sensitivity Enhancing Device - Product Description
Table 43: PET System - Product Status
Table 44: PET System - Product Description
Table 45: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Breast PET-MRI - Product Status
Table 47: Breast PET-MRI - Product Description
Table 48: Wrist Scanner - Product Status
Table 49: Wrist Scanner - Product Description
Table 50: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
Table 51: PET Imaging Tool - Product Status
Table 52: PET Imaging Tool - Product Description
Table 53: University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
Table 54: EXPLORER - Product Status
Table 55: EXPLORER - Product Description
Table 56: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
Table 57: DS-PS3 Positron Emission Tomography Detector - Product Status
Table 58: DS-PS3 Positron Emission Tomography Detector - Product Description
Table 59: High Resolution PET Detector - Product Status
Table 60: High Resolution PET Detector - Product Description
Table 61: PET-Mammogram-Biopsy System - Product Status
Table 62: PET-Mammogram-Biopsy System - Product Description
Table 63: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Positron Emission Tomography (PET) Imager - Product Status
Table 65: Positron Emission Tomography (PET) Imager - Product Description
Table 66: Glossary
1.2 List of Figures
Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report